System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Reinhard Büttner

Oncology — University Hospital Cologne, Germany

LeadR Profile

Reinhard Büttner University Hospital Cologne Germany
3 012 ScienceLeadR Reputation 3012

Unlock

Register Login
Network Map

Oncology

Subspecialties: Pulmonology - Hematology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026
Source: PubMed

University Hospital Cologne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1127

Citations

Citations: 53 149 1st author: 37 Last author: 144 Unique author: 11

Main journals

J Clin Oncol 48
Pathologe 34
Cancer Res 30
Int J Cancer 30
Z Gastroenterol 30

Best Journals

J Clin Oncol 14
Nature 9
Ann Oncol 7

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rationale and Study Design of the GUIDANCE trial: A Multicenter Phase II Trial of Maintenance Durvalumab and Olaparib After Standard Fist Line Treatment (Carboplatin/Cisplatin, Etoposide, and Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) (AIO-TRK-0124/ass).
cells, genes, recombination, genetic, lung, poly(adp-ribose) polymerases, homologous recombination, neoplasms, poly adenosine diphosphate ribose, biomarkers, maintenance, lung neoplasms, recombinational dna repair, small cell lung carcinoma, therapeutics, etoposide, carboplatin		Clin Lung Cancer20260
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.
cells, safety, neoplasms, carcinoma, non-small-cell lung, mutation		Clin Cancer Res20260
Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.
pregnancy, neoplasms, adenocarcinoma, survival analysis, proteomics, sex characteristics, sex, complement system proteins, prognosis, sex differences		Int J Cancer20260
Unified definition of integrated diagnostics: a position statement of the EFLM.
biomarkers, radiology		Clin Chem Lab Med20260
SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma.
cells, immunohistochemistry, neoplasms, adenocarcinoma, chromatin, therapeutics, chromosomes, mast cells		Sci Rep20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 2 2
Phase 3 1

By status:

Unknown 2
Active not recruiting 1
Completed 1
Recruiting 1

By type:

Interventional 3
Observational 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS